Literature DB >> 32896887

Prevalence, awareness, treatment and control of hypertension among adults in Kenya: cross-sectional national population-based survey.

Supa Pengpid1,2, Karl Peltzer3,4.   

Abstract

BACKGROUND: Hypertension is a major and fast-growing public health problem in Africa. AIMS: To determine the prevalence of hypertension and assess the levels of awareness, treatment and control in Kenya.
METHODS: A national cross-sectional study based on stratified cluster random sampling was conducted in 2015. The total sample included 4500 individuals aged 18-69 years, (60.0% female; median age 38.0 years, interquartile range 29-52 years) from Kenya. We used the World Health Organization STEPS method: Step 1, questionnaire interview; Step 2, anthropometric and blood pressure (BP) measurements; and Step 3, biochemical tests. Logistic regression was used to investigate the determinants of hypertension (systolic/diastolic) BP ³ 140/90 mm Hg or use of antihypertensive medication), and awareness, treatment and control.
RESULTS: Overall, 28.6% of the population had hypertension, 29.2% among men and 27.9% among women, 17.7% among individuals 18-29 years and 58.3% among those aged 60-69 years. Among hypertensives, 29.4% were aware, 6.5% were currently using antihypertensive medication, and 12.5% had controlled their BP (< 140/90 mmHg). In the fully adjusted model, older age, higher education, overweight and obesity, past month binge drinking, and type 2 diabetes were positively associated with hypertension. In addition, underweight was negatively associated with hypertension.
CONCLUSIONS: There was a high prevalence of hypertension among adults in Kenya, with low awareness, treatment and control rates. Public health response is needed in the form of integrated and comprehensive action targeting major noncommunicable diseases in the country.
Copyright © World Health Organization (WHO) 2020. Open Access. Some rights reserved. This work is available under the CC BY-NC-SA 3.0 IGO license (https://creativecommons.org/licenses/by-nc-sa/3.0/igo).

Entities:  

Keywords:  Kenya; awareness; control; hypertension; treatment

Mesh:

Substances:

Year:  2020        PMID: 32896887     DOI: 10.26719/emhj.20.063

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  5 in total

1.  Prevalence of hypertension in Shenzhen, China: a population-based, cross-sectional study.

Authors:  Weicong Cai; Yirong Wang; Ke Peng; Rencheng Zhao; Fangjiang Liu; Kaihao Lin; Fengzhu Xie; Lin Lei; Ji Peng
Journal:  BMJ Open       Date:  2022-06-21       Impact factor: 3.006

Review 2.  Prevalence of and risk factors for hypertension in Ethiopia: A systematic review and meta-analysis.

Authors:  Endalamaw Tesfa; Dessalegn Demeke
Journal:  Health Sci Rep       Date:  2021-09-22

3.  A comparison of unhealthy lifestyle practices among adults with hypertension aware and unaware of their hypertensive status: results from the 2013 WHO STEPS survey in Burkina Faso.

Authors:  Jeoffray Diendéré; Jean Kaboré; William Kofi Bosu; Jérome Winbetouréfâ Somé; Franck Garanet; Pingdéwendé Victor Ouédraogo; Abdoul Aziz Savadogo; Athanase Millogo; Augustin Nawidimbasba Zeba
Journal:  BMC Public Health       Date:  2022-08-23       Impact factor: 4.135

4.  National trends in prevalence, awareness, treatment, and control of hypertension among adults in Mongolia from 4 cross-sectional surveys in 2005, 2009, 2013, and 2019.

Authors:  Supa Pengpid; Karl Peltzer
Journal:  Medicine (Baltimore)       Date:  2022-08-19       Impact factor: 1.817

5.  Medication Adherence and Blood Pressure Control Among Hypertensive Outpatients Attending a Tertiary Cardiovascular Hospital in Tanzania: A Cross-Sectional Study.

Authors:  Pedro Pallangyo; Makrina Komba; Zabella S Mkojera; Peter R Kisenge; Smita Bhalia; Henry Mayala; Engerasiya Kifai; Mwinyipembe K Richard; Khuzeima Khanbhai; Salma Wibonela; Jalack Millinga; Robert Yeyeye; Nelson F Njau; Thadei K Odemary; Mohamed Janabi
Journal:  Integr Blood Press Control       Date:  2022-08-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.